111 – 120 of 183
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Prostate Cancer: To Treat or Not to Treat?
(
- Contribution to journal › Article
-
Mark
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Reduced risk of prostate cancer in infertile men compared to men with proven fertility: A nested case-control study
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.197-197(
- Contribution to journal › Published meeting abstract
-
Mark
The Identification of a Novel Stromal Stem/Progenitor Cell Phenotype in the Human Adult Prostate
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.93-93(
- Contribution to journal › Published meeting abstract
-
Mark
Association between tobacco exposure and reproductive parameters in adolescent males.
(
- Contribution to journal › Article
-
Mark
Nordic observational study evaluating safety and analgesic consumption in patients with advanced cancer under zoledronic acid (ZOMETA (R)) treatment: NOSAZ-interim analysis
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.232-232(
- Contribution to journal › Published meeting abstract
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
-
Mark
Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.278-278(
- Contribution to journal › Published meeting abstract
-
Mark
Do we need PSA and early detection of prostate cancer?
(
- Contribution to journal › Article
-
Mark
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
(
- Contribution to journal › Article